Upfront Combo Lipid-Lowering Therapy Best for Acute Coronary Syndrome
Combination approach better than statin monotherapy for all-cause mortality at 1, 3, and 5 years in acute coronary syndromes
Combination approach better than statin monotherapy for all-cause mortality at 1, 3, and 5 years in acute coronary syndromes
Inorganic nitrate also reduced the risk for major adverse cardiac events in patients undergoing coronary angiography for non-ST-elevation acute coronary syndrome.
Patients with stage 3 chronic kidney disease are at increased risk for contrast-induced acute kidney injury.
Inadequately treated acute coronary syndrome can result in heart failure and early death.
Patients with vs without chronic kidney disease have 32% lower odds of undergoing invasive cardiac procedures for acute coronary syndrome in adjusted analyses.
Researchers evaluated the safety and efficacy of transradial vs transfemoral access in patients with CKD undergoing PCI.
The researchers explored the association of sex with outcomes among patients treated with ticagrelor monotherapy vs ticagrelor plus aspirin.